Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

Fig. 2

Metabolic syndrome (MetS) prevalence rates among participants based on the ATP III and IDF criteria. Patients with mental illness who were maintained on antipsychotics (n = 112) for at least 6 months were compared to a control group (n = 114). No significant difference in the prevalence of MetS between the two groups. ATP III: Adult Treatment Panel III. IDF: International Diabetes Federation

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us